KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Equity Income (2016 - 2025)

Opko Health (OPK) has disclosed Equity Income for 14 consecutive years, with -$9000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Equity Income fell 200.0% year-over-year to -$9000.0, compared with a TTM value of -$24000.0 through Jun 2025, up 22.58%, and an annual FY2024 reading of -$18000.0, up 83.18% over the prior year.
  • Equity Income was -$9000.0 for Q1 2025 at Opko Health, up from -$12000.0 in the prior quarter.
  • Across five years, Equity Income topped out at -$3000.0 in Q1 2024 and bottomed at -$466000.0 in Q4 2021.
  • Average Equity Income over 5 years is -$71625.0, with a median of -$39500.0 recorded in 2023.
  • The sharpest move saw Equity Income tumbled 891.49% in 2021, then soared 95.06% in 2022.
  • Year by year, Equity Income stood at -$466000.0 in 2021, then skyrocketed by 95.06% to -$23000.0 in 2022, then surged by 65.22% to -$8000.0 in 2023, then crashed by 50.0% to -$12000.0 in 2024, then increased by 25.0% to -$9000.0 in 2025.
  • Business Quant data shows Equity Income for OPK at -$9000.0 in Q1 2025, -$12000.0 in Q4 2024, and -$3000.0 in Q3 2024.